http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-285357-A5

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b172e4dc6f8b115773eb99a04e8260f6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-02
filingDate 1985-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0190d1b8cff648c155e5cbe14917ff26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d313791b376b36c8693aa6937cbb7f1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f06191c5683ae92d4440d93ac6343ee
publicationDate 1990-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-285357-A5
titleOfInvention PROCESS FOR OBTAINING EPIMER-FREE ALPHA-ERGOKRYPTIN
abstract The present invention includes a method for recovering epimer-free α-ergokryptin from a mixture of α- and β-ergokryptinine ergocorninin enriched with up to 79% α-ergokryptinin by the method of re-epimerization. The object of the invention is achieved by reepimerization the pharmacologically inactive a- and b-ergokryptinine ergocorninine mixture optionally in an acetonic solution with the addition of alcoholic phosphoric acid and alcohol or in methanolic phosphoric solution with addition of methanol after heating the solution to 50C and leaving to stand at room temperature in epimer-free a-ergokryptinphosphat over. After release of the a-ergokryptin base from the ergocryptophosphate and crystallization as the a-ergokryptine aromatic adduct, an a-ergocryptine with a purity of at least 97% is obtained.
priorityDate 1985-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414856317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084035
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415860020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73453
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15586930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580652
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1061
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426726972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425966152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134551
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004

Total number of triples: 34.